- $587.45m
- $525.42m
- $1.92m
- 77
- 17
- 95
- 67
2019 March 31st | C2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6.5 | 1.56 | 0.921 | 1.08 | 1.92 |
Cost of Revenue | |||||
Gross Profit | -0.752 | 0.431 | 0.515 | 1.08 | 1.92 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 49.2 | 39.1 | 55.7 | 37.9 | 18.4 |
Operating Profit | -42.7 | -37.5 | -54.8 | -36.8 | -16.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -41.3 | -35.2 | -54.3 | -36.5 | -15.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -42 | -37.6 | -54.4 | -37.5 | -16.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -42 | -37.6 | -54.4 | -37.5 | -16.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -42 | -37.6 | -54.4 | -37.5 | -16.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.42 | -2.27 | -2.97 | -2.47 | -2.19 |